Prothena (PRTA)
(Delayed Data from NSDQ)
$20.87 USD
+0.31 (1.51%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.87 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Prothena Corporation plc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 91 | 54 | 201 | 1 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 91 | 54 | 201 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 282 | 185 | 129 | 114 | 87 |
Income After Depreciation & Amortization | -191 | -132 | 72 | -113 | -86 |
Non-Operating Income | 31 | 6 | 0 | 1 | 8 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -160 | -126 | 72 | -111 | -77 |
Income Taxes | -13 | -9 | 5 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -147 | -117 | 67 | -111 | -78 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -147 | -117 | 67 | -111 | -78 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -183 | -125 | 79 | -106 | -79 |
Depreciation & Amortization (Cash Flow) | 8 | 7 | 7 | 7 | 7 |
Income After Depreciation & Amortization | -191 | -132 | 72 | -113 | -86 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 53.22 | 47.37 | 48.46 | 39.92 | 39.88 |
Diluted EPS Before Non-Recurring Items | -2.76 | -2.47 | 1.38 | -2.78 | -1.95 |
Diluted Net EPS (GAAP) | -2.76 | -2.47 | 1.38 | -2.78 | -1.95 |
Fiscal Year end for Prothena Corporation plc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.32 | 84.87 | 4.02 | 2.17 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.32 | 84.87 | 4.02 | 2.17 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 78.83 | 74.56 | 70.52 | 58.50 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -78.51 | 10.31 | -66.50 | -56.33 |
Non-Operating Income | NA | 7.90 | 8.51 | 7.60 | 6.55 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -70.62 | 18.82 | -58.90 | -49.78 |
Income Taxes | NA | -3.14 | -3.09 | -4.31 | -2.91 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -67.48 | 21.91 | -54.60 | -46.86 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -67.48 | 21.91 | -54.60 | -46.86 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 53.67 | 58.00 | 53.12 | 52.50 |
Diluted EPS Before Non-Recurring Items | NA | -1.26 | 0.38 | -1.03 | -0.89 |
Diluted Net EPS (GAAP) | NA | -1.22 | 0.38 | -1.03 | -0.89 |